[HSF] HIT and CPB

[Claudia Teles]

Enrique,

How is the incidence of post surgical thrombosis in the patients who
received the protocol?
Have you performed doppler follow up for the next 3-6 months?
Thanks,

Claudia Teles


2007/6/1, EPS-CCV <epsccv at arrakis.es>:
>
> Hal
>
> Prostacyclin does not prevent antibodies forming / resistance developing,
> obviously. The reasons why we use it are its short half-life (epoprostenol 6
> minutes) and the complete inhibition of the heparin-dependent platelet
> aggregation induced by HIT-II. That way you can use heparin "safely".
>
> Of course we'd prefer not to use heparin. The thing is that neither
> bivalirudin nor ECT & TAS Analyzer are available here. In addition, "our"
> protocol seems to be safe and effective.
>
> Enrique P. de la Sota, FECTS
> Madrid - Spain
> _______________________________________________
> OpenHeart-L mailing list
>
> Send postings to:
> OpenHeart-L at lists.hsforum.com
>
> To UNSUBSCRIBE, to CHANGE email address, or to view archives:
> http://mmp.cjp.com/mailman/listinfo/openheart-l
>
> All messages transmitted by the OpenHeart-L are subject to the policies
> and
> disclaimers posted at:
> http://www.hsforum.com/listdisclaim
> -----------------------------------------
>



-- 
Claudia Teles
Hemostasis Section - Instituto Estadual de Cardiologia Aloysio de Castro
Hemostasis Lab coordinator - Diagnosticos da America